Corrigendum to “The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis” [Diabetes Epidemiology and Management 14 (2024) 100201]
Corrigendum to “The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis” [Diabetes Epidemiology and Management 14 (2024) 100201]. // Diabetes Epidemiology and Management. – URL: https://www.sciencedirect.com/science/article/pii/S2666970626000387?dgcid=rss_sd_all
Corrigendum to “The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis” [Diabetes Epidemiology and Management 14 (2024) 100201]. Diabetes Epidemiology and Management. https://www.sciencedirect.com/science/article/pii/S2666970626000387?dgcid=rss_sd_all
“Corrigendum to “The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis” [Diabetes Epidemiology and Management 14 (2024) 100201].” Diabetes Epidemiology and Management.
@article{article43026,
title = {Corrigendum to “The efficacy of a 24-hour preoperative pause for SGLT2-inhibitors in type II diabetes patients undergoing bariatric surgery to mitigate euglycemic diabetic ketoacidosis” [Diabetes Epidemiology and Management 14 (2024) 100201]},
journal = {Diabetes Epidemiology and Management},
url = {https://www.sciencedirect.com/science/article/pii/S2666970626000387?dgcid=rss_sd_all}
}